INIMMUNE CORP

MISSOULA, MT, 59802

Unclaimed

AI-Generated Company Overview

Generating overview from available records...

No company-reported description yet. Owners can add one after claiming the profile.

Derived from government recordsGov-sourced

1 record from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Prime	Department of Health and Human Services National Institutes of Health	DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES 75N93023C00042	—	$7,776,786	Jul 14, 2026	Sep 30, 2023 – Sep 29, 2028

Contract vehicles are shown only when present in the source record.

No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.

Company-managed. Self-reported, not verified by FedSub.

Not stated. Prime or subcontract history above is a record of past work, not an indication of current interest.

541714Research and Development in Biotechnology (except Nanobiotechnology)Primary(definition)
541512Computer Systems Design Services(definition)

No SBA certifications found in current sources.

Last synced Oct 25, 2026 · profile updated Oct 25, 2026

Claim the profile to add company-reported capabilities, a capability statement, and teaming preferences.